Medical oncologist, PhD in Traslational Oncology
Medical Oncology Unit 2, Molinette Hospital
University Hospital City of Science and Health of Turin, Italy
Sarcomatoid mRCC: ICI–ICI or ICI–TKI? 🧬
Meet-URO 33 Real-world data: ICI–ICI looked better on OS (HR 0.58) , but the gap faded after adjusting for baseline risk. Patient & disease features matter as much as the regimen. @meeturoIT -URO
https://t.co/Ff3Glm6RCP
Predicting IO outcomes in #mRCC shouldn't rely on a "black box"🎯
Out in npj Precision Oncology, the MEET-URO 15-AI study leverages Machine Learning to deliver data-driven predictors for clinical practice @meeturoIT
https://t.co/LWapGT06Cs
#OncoTwitter#UroOnc#ImmunoOncology
Great collaboration on the use of Artificial Intelligence for assessing prognostic biomarkers in mRCC patients treated with immunotherapy. This work provides a solid foundation for our upcoming research in the first-line setting!! @PrelajArsela@GFornarini@gbanna74@amg120395
What drives 1L treatment choices in mRCC today?🧑⚕️👩⚕️Our new paper offers a snapshot of current clinical decision-making patterns in real-world practice!! @meeturoIT https://t.co/r85sfszygm
Great collaboration on the use of Artificial Intelligence for assessing prognostic biomarkers in mRCC patients treated with immunotherapy. This work provides a solid foundation for our upcoming research in the first-line setting!! @PrelajArsela@GFornarini@gbanna74@amg120395
@RebuzziSara opens the 1st edition of "Hot Topics in Renal Cell Carcinoma" today in Turin!
Looking forward to an insightful discussion on the latest advances and complex clinical scenarios in metastatic RCC.
#KidneyCancer#OncoTwitter#RCC#MedicalEducation
A million thanks to @RebuzziSara for the invitation to speak at "Hot Topics in RCC." Looks like a terrific agenda & I'm excited to join friends @gbanna74, @g_procopio_, @Ric_Campi, @paolo_gontero, @RafaelFCoelho2 & others for a wonderful meeting. Agenda below - register at: https://t.co/dtBaMFQISy
"Hot Topics in Renal Cell Carcinoma:
what we know and looking to the future" Free registrationat the following link:
https://t.co/bhEyxEgfkq
All sessions will be available as recordings for registered participants.
"Hot Topics in Renal Cell Carcinoma:
what we know and looking to the future" Free registrationat the following link:
https://t.co/bhEyxEgfkq
All sessions will be available as recordings for registered participants.
Finally published!!! 😃 The assessment of the Meet-URO score in a first-line mRCC international cohort. Thanks to @gbanna74@amg120395
https://t.co/abJQJ7S4h1
🎉CONGRATULATIONS to @RebuzziSara, recipient of the KCA's Christopher G. Wood Rising Star Award for talented young #kidneycancer experts! The award will be presented at #IKCSEU26 don't miss her lecture!
Register 🔗 https://t.co/kVerY1CB2h
Oral at #IUCS25:
Updated Meet-URO score in mRCC outperforms IMDC in prognostic accuracy for OS in 1st-line IO combinations (n=1418, 31 centers).
Supports clinical use & trial stratification, aiding personalized treatment
@PasRescigno@OncoAlert#mRCC#Immunotherapy#Oncology
Best Poster International Urology Cancer Summit , Meet-URO 33: " Prognostic assessment of the Meet-URO score compared with the IIMDC score in Metastatic Renal Cell Caricinoma (mRCC) receiving 1st line systemic therapies".
Congratulazioni @RebuzziSara#IUCS25
A big thank to the steering committee of the @urologysummit and all the Meet URO 33 friends @meeturoIT This is just the start of this wonderful journey ❤️
Congratulations @RebuzziSara and Davide Bimbatti for winning best abstract award on @meeturoIT score #IUCS25 with an APC waiver to publish their study on @OncJournal thanks to @gbanna74 for a fantastic meeting!